Cancer Research AACR Membership  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 4332-4335, December 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawanobori, S.
Right arrow Articles by LaVia, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawanobori, S.
Right arrow Articles by LaVia, M. F.

Rosette Formation and Inhibition in Cervical Dysplasia and Carcinoma in Situ1

Shoichi Sawanobori2, Robert B. Ashman3, André J. Nahmias4, Benedict B. Benigno and Mariano F. LaVia

Departments of Pediatrics [S. S., R. B. A., A. J. N.], Gynecology and Obstetrics [B. B. B.], and Pathology [M. F. L.], Emory University School of Medicine, Atlanta, Georgia 30303

Total and early rosettes and rosette inhibition were measured in patients with cervical dysplasia and carcinoma in situ. Both total and early rosettes were significantly depressed in patients with carcinoma in situ; early rosettes were also significantly lower than were controls in women with severe dysplasia. Rosette inhibition titers were increased in most patients with moderate dysplasia and in all patients with either severe dysplasia or carcinoma in situ. Thus, the rosette inhibition test may be useful in detecting, in a precancerous state, patients at risk for cancer.

1 This study was supported by Contract N01 CP 4-3393 within the Virus Cancer Program of the National Cancer Institute and by a grant from the Smokeless Tobacco Council.

2 Present address: Department of Pediatrics, Yokohama City University School of Medicine, 3–46 Urafunecho Minamiku, Yokohama, Japan.

3 Present address: Department of Microbiology, John Curtin School of Medical Research, Australian National University, P. O. Box 334, Canberra, A. C. T. 2601, Australia.

4 To whom requests for reprints should be addressed, at Department of Pediatrics, Emory University School of Medicine, 69 Butler Street, S. E., Atlanta, Ga. 30303.

Received 6/ 3/77. Accepted 9/ 6/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.